| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |